Dyne Therapeutics (DYN) Cash & Equivalents (2019 - 2026)
Dyne Therapeutics' Cash & Equivalents was $676.11 million in Q2 2026, up 39.4% from $485.04 million a year earlier but down 10.2% from the prior quarter.
Powered by 
Analysis
Dyne Therapeutics (DYN) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Dyne Therapeutics came in at $893.37 million, up 105.2% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 24.3% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $435.45 million in FY2024 (+258.0%), $121.63 million in FY2023 (-29.3%), $172.15 million in FY2022 (-14.3%) and $200.83 million in FY2021 (-33.2%).
- Quarterly Cash & Equivalents has moved between $121.63 million (Q4 2023) and $893.37 million (Q4 2025) over five years.
- Compared with a year earlier, Cash & Equivalents has increased for four straight quarters, with growth averaging 104.0% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2024 (growth of 308.5%); the worst was Q1 2022 (a decline of 52.4%).
- Per Business Quant data, DYN's Cash & Equivalents in the three quarters before Q2 2026 was $753.1 million (Q1 2026), $893.37 million (Q4 2025) and $573.61 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Dyne Therapeutics | 2.67 Bn | 2.67 Bn | - | 676.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 676.11 Mn |
| Mar 31, 2026 | 753.10 Mn |
| Dec 31, 2025 | 893.37 Mn |
| Sep 30, 2025 | 573.61 Mn |
| Jun 30, 2025 | 485.04 Mn |
| Mar 31, 2025 | 472.26 Mn |
| Dec 31, 2024 | 435.45 Mn |
| Sep 30, 2024 | 532.16 Mn |
| Jun 30, 2024 | 608.20 Mn |
| Mar 31, 2024 | 272.04 Mn |
| Dec 31, 2023 | 121.63 Mn |
| Sep 30, 2023 | 130.28 Mn |
| Jun 30, 2023 | 167.61 Mn |
| Mar 31, 2023 | 181.11 Mn |
| Dec 31, 2022 | 172.15 Mn |
| Sep 30, 2022 | 144.90 Mn |
| Jun 30, 2022 | 135.98 Mn |
| Mar 31, 2022 | 147.97 Mn |
| Dec 31, 2021 | 200.83 Mn |
| Sep 30, 2021 | 229.04 Mn |
API Access
Dyne Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DYN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "DYN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DYN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();